Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by M., A.
Right arrow Articles by G., A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by M., A.
Right arrow Articles by G., A.
NEUROLOGY 1991;41:936
© 1991 American Academy of Neurology

Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration

Alison M., Emslie-Smith MB, PhD and Andrew G., Engel MD

Muscle Research Laboratory and Department of Neurology, Mayo Clinic, Rochester, MN.

Three adult patients, two with undifferentiated connective tissue disease and one with carcinoma, had a distinctive pathologic reaction pattern consisting of necrotizing myopathy, minimal cellular infiltration, and a microangiopathy with thick "pipestem" vessels and microvascular deposits of complement membrane attack complex. Quantitative analysis revealed focal capillary depletion. This pattern represents an immune-mediated microangiopathy and is distinct from that observed in other inflammatory myopathies.

Address correspondence and reprint requests to Dr. Andrew G. Engel, Mayo Clinic, Rochester, MN 55905.

Supported by NIH grant NS-6277 and a research grant from the Muscular Dystrophy Association.

Received September 12, 1990. Accepted for publication in final form November 8, 1990.




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
G J D Hengstman, H J ter Laak, W T M Vree Egberts, I E Lundberg, H M Moutsopoulos, J Vencovsky, A Doria, M Mosca, W J van Venrooij, and B G M van Engelen
Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy
Ann Rheum Dis, December 1, 2006; 65(12): 1635 - 1638.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. A. Amato and R. C. Griggs
Unicorns, dragons, polymyositis, and other mythological beasts
Neurology, August 12, 2003; 61(3): 288 - 289.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
T Miller, M T Al-Lozi, G Lopate, and A Pestronk
Myopathy with antibodies to the signal recognition particle: clinical and pathological features
J. Neurol. Neurosurg. Psychiatry, October 1, 2002; 73(4): 420 - 428.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by AAN Enterprises, Inc.